PME100612
Human EVA1C Protein; hFc Tag
Größe
£181.00
- SKU:
- PME100612
- Zusätzliche Namen:
- B18;B19;C21orf63;C21orf64;FAM176C;PRED34;SUE21
- Molekulargewicht:
- The protein has a predicted molecular mass of 56.6 kDa after removal of the signal peptide. The apparent molecular mass of EVA1C-hFc is approximately 55-70 kDa due to glycosylation.
- Reinheit:
- The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.
- Lagerbedingungen:
- Store at -20[o]C to -80[o]C for 12 months in lyophilized form. After reconstitution; if not intended for use within a month; aliquot and store at -80[o]C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Hersteller:
- DIMA Biotechnology Ltd
- Formulierung:
- Lyophilized from sterile PBS; pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
- Target:
- EVA1C
- EVA1C(Leu49-Glu320) hFc(Glu99-Ala330):
- EVA1C(Leu49-Glu320) hFc(Glu99-Ala330)
- Weitere Details:
- EVA1C (aliases C21orf63); first identified in 2001; is a membrane protein encoding-gene. EVA1C protein has been found in a variety of human tissues. Kanae Mitsunaga identified EVA1C protein possessing two repeats of putative ‘galactose-binding lectin domains’ that bind heparin. Although the role of EVA1C has not been reported in tumor; Manas Kotepui et al. reported that ADGRL3 (LPHN3); an important paralog of EVA1C gene; was upregulated in breast cancer and was correlated with axillary lymph node metastasis.
- Versandbedingungen:
- Ambient